Efficacy and Safety of Oral BT-11 in Ulcerative Colitis

Clinical trial NCT03861143 · COMPLETED

Trial details

NCT number: NCT03861143
Sponsor: NImmune Biopharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2019-08-14
Primary completion: 2020-12-10
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.